跳至主要内容
临床试验/NCT07291375
NCT07291375尚未招募1 期

The Effect of Low Dose Oral Amlodipine in Renal Protection From Contrast Induced Nephropathy in Diabetic Patients in Intensive Care Unit

Minia University0 个研究点目标入组 40 人开始时间: 2025年12月20日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
40
主要终点
measuring serum creatinine level

研究概览

简要总结

The aim is to assess the benefit of low dose oral amlodipine in renal protection from contrast induced nephropathy in diabetic patients in intensive care unit

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adult patients of both sexes (18:70) diabetic patients with serum creatinine below 1.2 hemodynamically stable patients ASA physical status 2,3

排除标准

  • patient refusal patients of chronic kidney diseases NPO patients serum creatinine above 1.2 Hypertensive patients

研究组 & 干预措施

Control group

Other

this group who undergoing iv contrast will receive hydration only

干预措施: Hydration (Other)

Amlodipine group

Other

this group will receive hydration and amlodipine

干预措施: Calcium channel blocker (Drug)

Amlodipine group

Other

this group will receive hydration and amlodipine

干预措施: Hydration (Other)

结局指标

主要结局

measuring serum creatinine level

时间窗: baseline

measuring serum creatinine level before the procedure and every day for 48 hours after

次要结局

未报告次要终点

研究者

发起方
Minia University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Andrew Samy Shafeek Shehata

Andrew Samy Shafeek

Minia University

相似试验